sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Middle East and Africa Embolization Agents Market...

Previsioni di mercato degli agenti di embolizzazione per Medio Oriente e Africa fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotto (bobine, tappi, perline/particelle, palloncini staccabili, colla, spugne, emboli liquidi, sclerosanti, agenti precipitanti e altri), applicazione ( Oncologia, Neurologia, Urologia, Cardiologia, Malattie vascolari periferiche e altri) e Utente finale (ospedali, centri cardiaci, centri chirurgici ambulatoriali e altri)

TIPRE00026129 | Pages: 155 | Medical Device | Nov 2021 | Type: Regional | Status: Published

Introduzione al mercato

Medio Oriente e Stati Uniti. Il mercato degli agenti di embolizzazione in Africa viene analizzato in base all\'Arabia Saudita, agli Emirati Arabi Uniti, al Sud Africa e al resto del Medio Oriente e del Medio Oriente. Africa. Nell’attuale scenario di mercato, la regione del Medio Oriente sta registrando una crescente incidenza di malattie croniche come ictus, disturbi neurologici, cancro e un aumento della popolazione geriatrica, adattando stili di vita non salutari. Inoltre, si prevede che l\'accettazione e l\'installazione di tecnologie moderne guideranno la crescita del mercato in questa regione. I fattori chiave che spingono il mercato includono la crescente incidenza di malattie croniche e l\'invecchiamento della popolazione. Fattori di rischio crescenti come l\'obesità, l\'ipertensione, la mancanza di attività fisica, e il fumo contribuiscono all’aumento dei casi di malattie cardiovascolari. Le malattie cardiovascolari sono la principale causa di morte, rappresentando oltre il 45% di tutti i decessi. L\'Arabia Saudita sta vivendo un cambiamento significativo nel tenore di vita e stile di vita; i cambiamenti hanno portato ad un aumento del consumo di cibi grassi e di scarsa qualità. La conseguenza di un cambiamento dello stile di vita ha portato all’aumento dei tassi di malattie cardiovascolari. Un altro fattore importante che aumenta i casi di malattie cardiovascolari in Arabia Saudita è l’aumento della popolazione geriatrica. Secondo il rapporto sull’invecchiamento della popolazione in Arabia Saudita, si prevede che la percentuale di persone in Arabia Saudita di età pari o superiore a 60 anni sarà pari al 25% della popolazione totale di 40 milioni entro la fine del 2050. Inoltre, il numero di persone di età pari o superiore a 80 anni si prevede che raggiungerà 1,6 milioni, ovvero il 4% della popolazione totale nello stesso periodo. Inoltre, il governo sta investendo massicciamente nella costruzione di ospedali per costruire un forte settore sanitario in Arabia Saudita. Ad esempio, nel 2019, il Ministero della Salute (MoH) ha pianificato la costruzione di 35 ospedali in tutto il paese. Il miglioramento della spesa sanitaria e le crescenti iniziative governative in Arabia Saudita sono fattori di crescita del mercato degli agenti di embolizzazione. Secondo il Consiglio di Cooperazione del Golfo (GCC), l\'Arabia Saudita prevede di investire 250 miliardi di SR (66,67 miliardi di dollari) in infrastrutture sanitarie e di aumentare la partecipazione del settore privato dall\'attuale 40% al 65% entro il 2030.

Il settore sanitario negli Emirati Arabi Uniti ha subito un numero considerevole di modifiche infrastrutturali e procedurali per posizionarsi come fornitore leader di assistenza sanitaria. Questi miglioramenti hanno attratto investimenti continui per il miglioramento delle infrastrutture dure e morbide durante la pandemia di COVID-19. A causa del COVID-19, in questa regione un numero considerevole di interventi di chirurgia elettiva pianificati sono stati annullati o rinviati. Dall\'inizio del 2020, la pandemia di COVID-19 ha causato enormi impatti sanitari e socioeconomici, che sono probabilmente continuerà anche nel 2021. La pandemia ha causato interruzioni nei servizi sanitari e ha influito sulla capacità dei paesi di affrontare e rispondere alle malattie non trasmissibili (NCD). Inoltre, le incertezze economiche e i conflitti in corso stanno peggiorando le condizioni in Medio Oriente e in Africa. Ad esempio, paesi come Siria, Libia e Yemen stanno soffrendo violenti conflitti e non sono stati in grado di attuare alcuna misura di sanità pubblica; inoltre, l\'Iran era in una profonda recessione economica a causa delle sanzioni statunitensi.

Panoramica e dinamiche del mercato

Il mercato degli agenti di embolizzazione in Medio Oriente e in Medio Oriente Si prevede che l’Africa crescerà da 124,75 milioni di dollari nel 2021 a 194,31 milioni di dollari entro il 2028; si stima che cresca ad un CAGR del 6,5% dal 2021 al 2028. Aumento dell\'incidenza di tumori e aneurismi; Gli agenti di embolizzazione vengono utilizzati per arrestare in modo acuto il flusso in un vaso sanguigno o in un territorio vascolare mediante occlusione meccanica. L’embolizzazione è una procedura comune nella radiologia interventistica. Gli agenti embolizzanti come le microsfere emboliche (perline) vengono utilizzati per limitare l\'apporto vascolare dei tumori e possono essere caricati con farmaci chemioterapici, che eluiscono e diffondono nel tessuto. Gli agenti embolici liquidi vengono utilizzati per impedire l\'afflusso di sangue all\'aneurisma o al tumore. Aiuta nella prevenzione della crescita di aneurismi e tumori che causano danni agli organi essenziali. Pertanto, la crescente prevalenza di aneurismi e tumori sta creando una forte domanda per Medio Oriente e Stati Uniti. Mercato degli agenti di embolizzazione in Africa.

Segmenti chiave del mercato

In base al prodotto, il mercato è segmentato in bobine, perline/particelle, tappi, palloncini staccabili, colla, spugne, embolici liquidi, sclerosanti, agenti precipitanti, altri. Il segmento perle/particelle ha detenuto la quota maggiore del mercato nel 2020. In base alle bobine, il mercato è suddiviso in bobine rimovibili e bobine spingebili. Il segmento delle bobine spingebili ha detenuto la quota maggiore del mercato nel 2020. In base alle perle/particelle il mercato è suddiviso in sferiche e non sferiche. Il segmento non sferico spingebile deteneva la quota maggiore del mercato nel 2020. In base all\'applicazione, il mercato è segmentato in neurologia, oncologia, cardiologia, malattie vascolari periferiche e altri. Nel 2020, il segmento oncologico deterrà probabilmente la quota maggiore del mercato. Il mercato degli agenti di embolizzazione per utente finale è segmentato in ospedali, centri chirurgici ambulatoriali, centri cardiaci e altri. Il segmento ospedaliero ha detenuto la quota maggiore del mercato nel 2020.

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato degli agenti di embolizzazione in Medio Oriente e Stati Uniti. Africa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti del governo nazionale e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Abbott; Società scientifica di Boston; Cook Medical LLC; DePuy sintetizza; CORPORAZIONE KANEKA; Medtronic; Merito Medical Systems Inc; Stryker Corporation; e Terumo Corporation, tra gli altri.

Motivi per acquistare il rapporto

  • Capire il Medio Oriente e il Medio Oriente Il panorama del mercato degli agenti di embolizzazione in Africa e identifica i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
  • Stai al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il Medio Oriente e l\'Europa. Mercato degli agenti di embolizzazione in Africa
  • Pianificare in modo efficiente fusioni e acquisizioni e accordi di partnership in Medio Oriente e in Medio Oriente. Mercato degli agenti di embolizzazione in Africa identificando i segmenti di mercato con le vendite probabili più promettenti
  • Aiuta a prendere decisioni aziendali consapevoli dall\'analisi perspicace e completa delle prestazioni di mercato di vari segmenti dal Medio Oriente e dall\'Europa. Mercato degli agenti di embolizzazione in Africa
  • Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 in Medio Oriente e Asia. Regione africana.

MEDIO ORIENTE e amp; SEGMENTAZIONE DEL MERCATO DEGLI AGENTI EMBOLIZZATORI DELL\'AFRICA

Per prodotto

  • Bobine
    • Bobine rimovibili
    • Bobine spingebili
  • Perline/Particelle
    • Sferica
    • Non sferica
  • Tappi
  • Palloncini staccabili
  • Colla
  • Spugna
  • Embolici liquidi
  • Sclerosanti
  • Agenti precipitanti
  • Altri

 

Per Applicazione

  • Oncologia
  • Neurologia
  • Urologia
  • Cardiologia
  • Malattie vascolari periferiche
  • Altro

Perutente finale

  • Ospedali
  • Centri cardiaci
  • Centri chirurgici ambulatoriali
  • Altri  

Per Paese

  • Arabia Saudita
  • Sudafrica
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e del Medio Oriente Africa

Profili aziendali

  • Abbott
  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • KANEKA CORPORATION
  • Medtronic
  • Merit Medical Systems Inc
  • Stryker Corporation
  • Terumo Corporation

1.           Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        MEA Embolization Agents Market – By Product

1.3.2        MEA Embolization Agents Market – By Application

1.3.3        MEA Embolization Agents Market – By End User

1.3.4        MEA Embolization Agents Market – By Country

2.           MEA Embolization Agents Market – Key Takeaways

3.       Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           MEA Embolization Agents Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Middle East & Africa – PEST Analysis

4.3       Experts Opinion

5.           MEA Embolization Agents Market– Key Market Dynamics

5.1       Market Drivers

5.1.1        Surge in the Incidence of Tumors and Aneurysms

5.1.1        Rising Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2       Market Restraints

5.2.1        High Cost of Embolization Agents

5.3       Market Opportunities

5.3.1        Growing Geriatric Population Base

5.4       Future Trends

5.4.1        Technological Advancements in Embolization Products and Procedures

5.5       Impact analysis

6.           Embolization Agents Market – MEA Analysis

6.1       MEA Embolization Agents Market Revenue Forecast and Analysis

7.           MEA Embolization Agents Market Analysis – By Product

7.1       Overview

7.2       MEA Embolization Agents Market Revenue Share, by Product (2021 and 2028)

7.3       Coils

7.3.1        Overview

7.3.2        Coils: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.3.2.1      Detachable Coils

7.3.2.1.1       Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1.2       Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2      Pushable Coils

7.3.2.2.1       Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2.2       Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Beads/Particles

7.4.1        Overview

7.4.2        Beads/Particles: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.4.2.1      Spherical

7.4.2.1.1       Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.1.2       Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.2.2      Non-Spherical

7.4.2.2.1       Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.2.2       Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Plugs

7.5.1        Overview

7.5.2        Plugs: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.6       Detachable Balloons

7.6.1        Overview

7.6.2        Detachable Balloons: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.7       Glue

7.7.1        Overview

7.7.2        Glue: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.8       Sponge

7.8.1        Overview

7.8.2        Sponge: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.9       Liquid Embolics

7.9.1        Overview

7.9.2        Liquid Embolics: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.10    Sclerosants

7.10.1     Overview

7.10.2     Sclerosants: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.11    Precipitating Agents

7.11.1     Overview

7.11.2     Precipitating Agents: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.12    Others

7.12.1     Overview

7.12.2     Others: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

8.           MEA Embolization Agents Market Analysis – By Application

8.1       Overview

8.2       MEA Embolization Agents Market, by Application 2021 & 2028 (%)

8.3       Oncology

8.3.1        Overview

8.3.2        Oncology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4       Neurology

8.4.1        Overview

8.4.2        Neurology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5       Urology

8.5.1        Overview

8.5.2        Urology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.6       Cardiology

8.6.1        Overview

8.6.2        Cardiology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.7       Peripheral Vascular Diseases

8.7.1        Overview

8.7.2        Peripheral Vascular Diseases: MEA Embolization Agents Market – Revenue and Forecast to 2028  (US$ Million)

8.8       Others

8.8.1        Overview

8.8.2        Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.           MEA Embolization Agents Market Analysis – By End User

9.1       Overview

9.2       MEA Embolization Agents Market Revenue Share, By End User (2021 and 2028)

9.3       Hospitals

9.3.1        Overview

9.3.2        Hospitals: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.4       Cardiac Centers

9.4.1        Overview

9.4.2        Cardiac Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.5       Ambulatory Surgical Centers

9.5.1        Overview

9.5.2        Ambulatory Surgical Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.6       Others

9.6.1        Overview

9.6.2        Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.        MEA Embolization Agents Market – Country Analysis

10.1    Middle East & Africa: Embolization Agents Market

10.1.1     Overview

10.1.2     Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)

10.1.2.1    Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1    Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2    Saudi Arabia Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1        Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.1.2.2        Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.1.3    Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4    Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2    UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1    UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2    UAE Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1        UAE: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.2.2.2        UAE: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.2.3    UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4    UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3    South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1    South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2    South Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1        South Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.3.2.2        South Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.3.3    South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4    South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4    Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1    Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2    Rest of Middle East and Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028  (USD Million)

10.1.2.4.2.1        Rest of Middle East and Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.4.2.2        Rest of Middle East and Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.4.3    Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4    Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on MEA Embolization Agents Market

11.1    Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.        MEA Embolization Agents Market–Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1    Medtronic

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Terumo Corporation

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Cook Medical LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Boston Scientific Corporation

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Abbott

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Stryker Corporation

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Merit Medical Systems Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    DePuy Synthes

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    KANEKA CORPORATION

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms


LIST OF TABLES

Table 1.             MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)

Table 2.             Saudi Arabia Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 10.          UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 11.          UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 15.          South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 16.          South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of Middle East and Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028  (USD Million)

Table 18.          Rest of Middle East and Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028  (USD Million)

Table 19.          Rest of Middle East and Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 22.          Organic Developments Done by Companies

Table 23.          Inorganic Developments Done by Companies

Table 24.          Glossary of Terms, MEA Embolization Agents Market

 


LIST OF FIGURES

Figure 1.           MEA Embolization Agents Market Segmentation

Figure 2.           MEA Embolization Agents Market Segmentation, By Country

Figure 3.           MEA Embolization Agents Market Overview

Figure 4.           Beads/ Particles Segment Held the Largest Share of the Product Segment in MEA Embolization Agents Market

Figure 5.           UAE to Show Significant Growth During Forecast Period

Figure 6.           Middle East & Africa PEST Analysis

Figure 7.           MEA Embolization Agents Market Impact Analysis of Drivers and Restraints

Figure 8.           MEA Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           MEA Embolization Agents Market Revenue Share, by Product (2021 and 2028)

Figure 10.        Coils: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Beads/Particles: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Plugs: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Detachable Balloons: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Glue: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Sponge: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Liquid Embolics: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Sclerosants: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Precipitating Agents: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Others: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        MEA Embolization Agents Market, by Application 2021 & 2028 (%)

Figure 21.        Oncology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Neurology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Urology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Cardiology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Peripheral Vascular Diseases: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        MEA Embolization Agents Market Revenue Share, By End User (2021 and 2028)

Figure 28.        Hospitals: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Cardiac Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Ambulatory Surgical Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Middle East and Africa: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)

Figure 33.        Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)

Figure 34.        Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

 

  1. Abbott
  2. Boston Scientific Corporation
  3. Cook Medical LLC
  4. DePuy Synthes
  5. KANEKA CORPORATION
  6. Medtronic
  7. Merit Medical Systems Inc
  8. Stryker Corporation
  9. Terumo Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Embolization Agents Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription